GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Days Sales Outstanding

Gentian Diagnostics AS (OSL:GENT) Days Sales Outstanding : 36.85 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Days Sales Outstanding?

Gentian Diagnostics AS's average Accounts Receivable for the three months ended in Dec. 2024 was kr17.2 Mil. Gentian Diagnostics AS's Revenue for the three months ended in Dec. 2024 was kr42.6 Mil. Hence, Gentian Diagnostics AS's Days Sales Outstanding for the three months ended in Dec. 2024 was 36.85.

The historical rank and industry rank for Gentian Diagnostics AS's Days Sales Outstanding or its related term are showing as below:

OSL:GENT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.21   Med: 40.39   Max: 67.66
Current: 44.29

During the past 12 years, Gentian Diagnostics AS's highest Days Sales Outstanding was 67.66. The lowest was 29.21. And the median was 40.39.

OSL:GENT's Days Sales Outstanding is ranked better than
78.87% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: 66.04 vs OSL:GENT: 44.29

Gentian Diagnostics AS's Days Sales Outstanding declined from Dec. 2023 (43.12) to Dec. 2024 (36.85).


Gentian Diagnostics AS Days Sales Outstanding Historical Data

The historical data trend for Gentian Diagnostics AS's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Days Sales Outstanding Chart

Gentian Diagnostics AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.00 31.06 29.77 29.21 41.84

Gentian Diagnostics AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.12 40.67 55.18 48.35 36.85

Competitive Comparison of Gentian Diagnostics AS's Days Sales Outstanding

For the Medical Devices subindustry, Gentian Diagnostics AS's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gentian Diagnostics AS's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Days Sales Outstanding falls into.


;
;

Gentian Diagnostics AS Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Gentian Diagnostics AS's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (11.569 + 23.293) / 2 ) / 152.07*365
=17.431 / 152.07*365
=41.84

Gentian Diagnostics AS's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (11.126 + 23.293) / 2 ) / 42.61*365 / 4
=17.2095 / 42.61*365 / 4
=36.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gentian Diagnostics AS  (OSL:GENT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Gentian Diagnostics AS Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Gentian Diagnostics AS Business Description

Traded in Other Exchanges
Address
Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.

Gentian Diagnostics AS Headlines